MDGL Stock-Based Compensation
Madrigal Pharmaceuticals Inc · Stock-Based Compensation
MDGL Stock-Based Compensation
Latest reported$95.64Mperiod ending
MDGL Stock-Based Comp ($0.00 → $95.64M)
Annual stock-based compensation
High-resolution chart · PNG
MDGL stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 98,130,000 | |
| 79,880,000 | |
| 49,735,000 | |
| 31,625,000 | |
| 26,873,000 | |
| 20,730,000 | |
| 22,759,000 | |
| 13,489,000 | |
| 3,254,000 | |
| 8,679,174 | |
| 4,300,000 | |
| 7,431,000 | |
| 6,030,000 | |
| 3,322,000 | |
| 3,354,000 | |
| 4,048,000 | |
| 4,579,000 | |
| 7,572,000 | |
| 5,417,000 | |
| 4,791,000 | |
| 0 | |
| 0 | |
| 0 |